Skip to main content
Year archive

PERCHERON THERAPEUTICS LIMITED — 2018 filings

All 47 regulatory filings released by PERCHERON THERAPEUTICS LIMITED (PER) in 2018, sourced directly from the official regulator.

47 Filings
2018 Period
2018 filings (47)
Filing Released Lang
Receipt of R&D Tax Incentive payment 1 page 90.9KB
Capital/Financing Update
2018-12-03 English
AGM Presentation 13 pages 1.7MB
AGM Information
2018-11-28 English
Results of Meeting 2 pages 180.7KB
Declaration of Voting Results & Voting Rights Announcements
2018-11-28 English
Appendix 4G 13 pages 186.6KB
Governance Information
2018-11-08 English
Change of Director's Interest Notice (MD) 2 pages 137.9KB
Director's Dealing
2018-11-01 English
Change of Director's Interest Notice (RM) 2 pages 138.1KB
Director's Dealing
2018-11-01 English
Investor Presentation 17 pages 1.8MB
Investor Presentation
2018-10-29 English
Appendix 4C - quarterly 5 pages 202.7KB
Interim / Quarterly Report
2018-10-28 English
Notice of Annual General Meeting/Proxy Form 86 pages 4.4MB
AGM Information
2018-10-28 English
Response to ASX Price and Volume Query 5 pages 170.6KB
Regulatory Filings
2018-10-15 English
Duchenne ACTT Now Conference 2018 2 pages 118.6KB
Regulatory Filings
2018-09-05 English
Pause in Trading 1 page 112.9KB
Regulatory Filings
2018-08-28 English
First Patient Dosed in Phase II DMD Clinical Trial 2 pages 126.3KB
Regulatory Filings
2018-08-28 English
Full Year Statutory Accounts 71 pages 1.1MB
Annual Report
2018-08-28 English
ANP to Present at 14th Annual Bioshares Biotech Summit 12 pages 1.0MB
Investor Presentation
2018-07-26 English
Change of Director's Interest Notice (RM) 2 pages 22.4KB
Director's Dealing
2018-07-25 English
Appendix 4C - quarterly 5 pages 520.0KB
Interim / Quarterly Report
2018-07-23 English
Company Appointment 2 pages 116.9KB
Board/Management Information
2018-07-22 English
ANP initiates ATL1102 Phase II clinical trial in DMD 2 pages 106.7KB
Regulatory Filings
2018-07-15 English
Appendix 3B 13 pages 704.4KB
Share Issue/Capital Change
2018-06-27 English
ATL1103/atesidorsen Early Access Program Progress Update 2 pages 47.5KB
Regulatory Filings
2018-06-13 English
121 Tech Investment Hong Kong Conference Presentation 16 pages 795.5KB
Investor Presentation
2018-06-13 English
Change of Director's Interest Notice - WG 2 pages 109.3KB
Director's Dealing
2018-05-31 English
ATL1103 Phase II trial results published in leading journal 2 pages 33.7KB
Regulatory Filings
2018-05-22 English
Response to ASX Price & Volume Query 5 pages 171.6KB
Regulatory Filings
2018-05-13 English
Becoming a substantial holder 3 pages 145.1KB
Regulatory Filings
2018-05-08 English
Appendix 3B - Completion of Allotment 12 pages 727.1KB
Capital/Financing Update
2018-05-08 English
Change of Director's Interest Notice - (RM, MD, GP, WG, GM) 10 pages 416.6KB
Director's Dealing
2018-05-08 English
Appendix 3B 12 pages 717.5KB
Share Issue/Capital Change
2018-05-06 English
Top 20 securityholders 3 pages 177.5KB
Major Shareholding Notification
2018-05-06 English
$5 Million Capital Raising Completion 1 page 122.9K
Capital/Financing Update
2018-05-02 English
Corporate Presentation 16 pages 1.6MB
Investor Presentation
2018-04-30 English
Appendix 4C - quarterly 5 pages 81.1KB
Interim / Quarterly Report
2018-04-22 English
Cleansing Notice 15 pages 83.5KB
Capital/Financing Update
2018-04-15 English
Becoming a substantial holder from AEF 3 pages 250.1KB
Major Shareholding Notification
2018-04-09 English
Placement Completion and Entitlement Issue 2 pages 143.9KB
Capital/Financing Update
2018-04-05 English
Appendix 3B 13 pages 815.7KB
Capital/Financing Update
2018-04-05 English
Entitlement Offer Booklet 14 pages 94.2KB
Capital/Financing Update
2018-04-05 English
Cleansing Notice 1 page 124.3KB
Capital/Financing Update
2018-04-05 English
Letters to Shareholders and Optionholders 3 pages 70.4KB
Capital/Financing Update
2018-04-05 English
Letter to Optionholders 1 page 76.8KB
Capital/Financing Update
2018-04-05 English
Institutional Placement and Rights Issue 2 pages 235.8KB
Capital/Financing Update
2018-04-02 English
Trading Halt 2 pages 754.6KB
Capital/Financing Update
2018-03-27 English
Half Year Accounts Appendix 4D 25 pages 499.3KB
Interim / Quarterly Report
2018-02-27 English
ATL1102 Ethics Committee Approval for DMD 3 pages 61.4KB
Regulatory Filings
2018-02-27 English
ATL1103/atesidorsen Early Access Program - Update 2 pages 46.0KB
Capital/Financing Update
2018-02-25 English
Appendix 4C - quarterly 5 pages 934.6KB
Interim / Quarterly Report
2018-01-28 English